Clinical Trials Related to GlaxoSmithKline

Related studies linked through entity extraction aliases.

Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks

Status: COMPLETED
Phase: PHASE3

A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)

Status: RECRUITING
Phase: PHASE2

Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil

Status: ACTIVE_NOT_RECRUITING
Phase: N/A

A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis

Status: TERMINATED
Phase: PHASE2

A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy Participants

Status: WITHDRAWN
Phase: PHASE1

A Study on the Reactogenicity, Safety and Immune Response of a Targeted Immunotherapy Against HSV in Healthy Japanese Participants Aged 18-40 Years

Status: COMPLETED
Phase: PHASE1

Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and/or Refractory Multiple Myeloma

Status: COMPLETED
Phase: N/A

Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2

Status: TERMINATED
Phase: PHASE1

Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum

Status: COMPLETED
Phase: PHASE1

Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults

Status: COMPLETED
Phase: PHASE1/PHASE2

A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults

Status: COMPLETED
Phase: PHASE1

A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults

Status: COMPLETED
Phase: PHASE3

Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer

Status: RECRUITING
Phase: PHASE2

A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

Status: COMPLETED
Phase: PHASE2

PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma

Status: RECRUITING
Phase: NA

Herpes Zoster Hospitalizations in Italy

Status: RECRUITING
Phase: N/A

A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease

Status: COMPLETED
Phase: PHASE4

Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma

Status: RECRUITING
Phase: PHASE2

A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above

Status: COMPLETED
Phase: PHASE2

A Study to Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy

Status: COMPLETED
Phase: PHASE3